Week In Review: Hansoh Sells Ex-China ADC Rights To GSK In $1.6 Billion Deal
October 28, 2023 at 15:40 PM EDT
Hansoh Pharma sold ex-China rights for its B7-H4 ADC to GSK in a $1.57 billion deal. Meanwhile, OrbiMed has raised $4.3 billion in commitments for three healthcare funds, including $751 million for its OrbiMed Asia V fund.
